TerrAscend stock (CA88160R1087): cannabis operator posts solid quarterly revenue while market eyes US growth

TerrAscend reported quarterly revenue of about $65.5 million in early May 2026, while its OTC-listed shares remain volatile. US investors are watching the multistate cannabis operator’s path to profitability and potential regulatory shifts in the United States.

TerrAscend, a North American cannabis operator listed over the counter in the United States, recently reported quarterly revenue of roughly $65.5 million and continues to show negative earnings, according to data summarized by MarketBeat for its May 7, 2026 earnings release (MarketBeat as of 05/18/2026). The stock, which trades under the ticker TSNDF on the OTC market, reflects ongoing volatility as investors assess the company’s exposure to key US state markets and the broader regulatory environment for cannabis.

As of: 05/18/2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: TerrAscend
• Sector/industry: Cannabis, consumer staples
• Headquarters/country: Canada
• Core markets: Selected US states and Canada
• Key revenue drivers: Retail dispensaries and cannabis production
• Home exchange/listing venue: OTC Markets (TSNDF), Canadian listing
• Trading currency: USD (OTC), CAD (Canada)

TerrAscend: core business model

TerrAscend operates as a vertically integrated cannabis company with activities spanning cultivation, processing and retail. The group focuses on regulated medical and adult?use markets, particularly in the United States, with operations in states such as New Jersey, Maryland and Michigan, alongside activities in Canada, according to company and sector profiles that describe its multistate footprint (HempGazette as of 05/18/2026). This integrated setup is intended to give the company control over its supply chain and branding while capturing margin across multiple steps.

The business model typically combines wholesale sales of cannabis products with revenue from branded retail stores. TerrAscend’s dispensaries sell flower, vapes, extracts and other derivative products, and the company sources a substantial portion of this inventory from its own cultivation and processing facilities, in line with many peers in the US cannabis sector. This vertical approach can provide cost efficiencies but also requires significant capital expenditure to establish cultivation sites, processing plants and retail outlets.

As a Canadian?domiciled operator with a strong US orientation, TerrAscend must comply with different regulatory frameworks at the provincial, state and federal levels. In Canada, federal legalization has enabled a nationwide legal framework, while in the US cannabis remains federally illegal but allowed in numerous states for medical or adult?use purposes. The company’s model is therefore built on navigating licensing processes, product regulations and taxation regimes, which can differ markedly from one jurisdiction to another. These regulatory complexities represent both a barrier to entry and an ongoing cost factor.

Another key element of TerrAscend’s business model is its focus on brand development and differentiated product offerings. The company’s strategy includes building recognizable house brands and tailoring product portfolios to local consumer preferences, from premium flower to value?oriented offerings. In an increasingly competitive market, brand strength and shelf presence can be important drivers of pricing power and repeat purchases. TerrAscend’s integrated operations allow it to support these brands from cultivation through to retail display.

Because cannabis remains a relatively young legal industry, TerrAscend’s model also involves an element of market education and relationship building with regulators and local communities. Operators in this space typically invest in compliance teams, community outreach and training to maintain good standing in their key markets. These efforts can influence license renewals and expansion opportunities, and they shape how the company positions itself as a long?term player in the legal cannabis value chain.

Main revenue and product drivers for TerrAscend

TerrAscend’s revenue is largely driven by sales of cannabis products through its retail dispensaries and wholesale channels. The company reported quarterly revenue of about $65.54 million around its May 7, 2026 earnings date, according to figures compiled by MarketBeat, which also noted that this result was modestly ahead of analyst expectations for the quarter (MarketBeat as of 05/18/2026). Over the trailing twelve months, TerrAscend has generated annual revenue in the area of $260 million, while still posting a net loss, highlighting the balance between top?line growth and profitability pressures in the sector.

Within that revenue base, adult?use and medical sales from key US states are particularly important. Markets like New Jersey and Maryland have seen growing legal cannabis demand, and multistate operators with strong retail positions can capture a significant share of this spending. TerrAscend’s combination of cultivation, processing and retail in these jurisdictions allows it to offer a broad range of products and respond to local regulatory changes, although specific state?level revenue splits are not always disclosed in detail in publicly available aggregations.

The company’s product portfolio typically includes dried flower, pre?rolls, vape cartridges, concentrates and edibles, reflecting consumer trends in legal cannabis markets. Higher?margin items such as concentrates and branded derivative products can play an outsized role in profitability, even if they represent a smaller share of volume. TerrAscend’s strategy, as described in various company materials and sector coverage, appears to emphasize differentiated branded products and premium categories, which can help offset pricing pressure in more commoditized segments like bulk flower.

Another revenue driver is wholesale supply to other retailers or brands, particularly in markets where TerrAscend operates large cultivation or processing facilities. Wholesale contracts can provide scale benefits and help absorb fixed costs associated with operating greenhouses, indoor grow rooms and extraction facilities. However, wholesale prices in the cannabis industry can be volatile, influenced by supply expansions, regulatory changes and shifts in consumer demand. Balancing wholesale exposure with more stable retail revenue is therefore an ongoing consideration for the company.

While revenue growth remains central, TerrAscend’s earnings profile highlights continuing net losses. MarketBeat data referencing its May 7, 2026 earnings release cites a quarterly loss per share of roughly $0.03 and a trailing EPS of about -$0.41, reflecting the cost of operating and expanding in heavily regulated markets (MarketBeat as of 05/18/2026). For investors, the sustainability of the company’s revenue mix, its path toward positive cash flow and its ability to manage operating expenses and finance costs are key areas of focus.

Why TerrAscend matters for US investors

For US investors, TerrAscend represents exposure to the evolving legal cannabis market through a company with operations in several US states but a Canadian domicile. The stock trades on the OTC market in the United States, which can make it accessible through many brokerage platforms, although liquidity and trading spreads may differ from those of major exchange?listed securities. As a vertically integrated operator with revenue concentrated in regulated state markets, TerrAscend’s performance is closely linked to the trajectory of US cannabis legalization and state?level regulatory developments.

The company’s presence in growth markets such as New Jersey and Maryland, which have expanded adult?use programs in recent years, provides a direct link to consumer spending on legal cannabis products. For investors seeking thematic exposure to consumer trends and regulatory change in the US, TerrAscend’s business offers a combination of retail and production assets that may respond to changes in patient and consumer demand, taxation policies and licensing frameworks. At the same time, the company’s reported net losses and ongoing investment needs underline that the sector remains in a build?out phase rather than a mature, stable stage.

US investors also need to consider the broader policy context, including the federal status of cannabis, potential banking reforms and tax rules that affect profitability for operators. Companies like TerrAscend can be sensitive to news about federal rescheduling debates, SAFE banking legislation proposals or state?level regulatory adjustments. Such developments may influence access to capital, cost of borrowing and the valuation environment for US?exposed cannabis stocks, making regulatory news a key catalyst for share price movements alongside company?specific earnings releases.

Conclusion

TerrAscend has established itself as a vertically integrated cannabis operator with a focus on key US state markets and a Canadian base, delivering quarterly revenue of around $65.5 million while still reporting a net loss. The company’s mix of cultivation, processing and retail assets offers exposure to growth in regulated cannabis consumption, but also carries the risks associated with high capital intensity, regulatory complexity and earnings volatility. For US?based investors who follow the cannabis theme, TerrAscend’s OTC?traded shares provide one way to track developments in this evolving industry without making any assumptions about future price direction or company?specific outcomes.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.